Heart Test Laboratories announced that intellectual property exclusively licensed to HeartSciences has received a notice of allowance from the United States Patent and Trademark Office for the detection of left ventricular and/or right ventricular dysfunction using deep learning, further strengthening the Company’s AI-ECG IP portfolio.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSCS:
- Heart Test Laboratories regains compliance with Nasdaq listing requirements
- HeartSciences Regains Compliance with Nasdaq Listing Requirements
- HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
- Heart Test announces internationalization of its AI-ECG patent portfolio
- Heart Test Laboratories Inc trading halted, news pending